共 231 条
[1]
Chen N(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet (London, England) 395 507-513
[2]
Zhou M(2021)Dexamethasone in hospitalized patients with COVID-19 N Engl J Med 384 693-704
[3]
Dong X(2021)Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial Lancet Respir Med 9 1407-1418
[4]
Qu J(2021)Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody sotrovimab N Engl J Med 385 1941-1950
[5]
Gong F(2022)Early remdesivir to prevent progression to severe COVID-19 in outpatients N Engl J Med 386 305-315
[6]
Han Y(2022)Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19 N Engl J Med 386 1397-1408
[7]
Horby P(2022)Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients N Engl J Med 386 509-520
[8]
Lim WS(2022)Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial Lancet Glob Health 10 e42-e51
[9]
Emberson JR(2021)REGEN-COV antibody combination and outcomes in outpatients with COVID-19 N Engl J Med 385 e81-179
[10]
Mafham M(2021)Emerging treatment strategies for COVID-19 infection Clin Exp Med 21 167-771